# Opaleye Management Inc.: insider transactions

SEC CIK 1595855. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-26.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Grace Therapeutics, Inc.](/companies/grce.md) | 10% owner | 2 | 2026-10-22 | 2026-10-26 |

## Transactions: 2

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Grace Therapeutics, Inc.](/companies/grce.md) | Purchase (P) | 66,411 | $1.7679 | $117.4k | [Form 4](/filings/0001493152-26-048591.md) |
| 2026-10-22 | [Grace Therapeutics, Inc.](/companies/grce.md) | Purchase (P) | 21,390 | $1.9258 | $41.2k | [Form 4](/filings/0001493152-26-048591.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 13:09 ET. No prices; not investment advice.